Access cutting-edge melanoma treatment through this clinical trial at a research site in La Jolla. Study-provided care at no cost to qualified participants.
Access melanoma specialists in La Jolla at no cost
This study follows strict safety protocols and ethical guidelines
All study-related melanoma treatment provided free
This phase II trial studies how well binimetinib and imatinib work in treating patients with stage III-IV KIT-mutant melanoma that cannot be removed by surgery (unresectable). Binimetinib and imatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving binimetinib and imatinib may help treat patients with KIT-mutant melanoma.
Sponsor: University of California, San Francisco
Check if you qualify for this melanoma clinical trial in La Jolla, CA
If you're searching for melanoma treatment options in La Jolla, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our La Jolla research site is actively enrolling participants for this clinical trial. You'll receive care from experienced melanoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.